BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 179 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,597,170 | +8.3% | 649,318 | +7.7% | 0.01% | -12.5% |
| Q2 2023 | $4,245,745 | -9.4% | 603,089 | +7.3% | 0.01% | -11.1% |
| Q1 2023 | $4,687,588 | -28.1% | 562,061 | -1.0% | 0.01% | -30.8% |
| Q4 2022 | $6,519,480 | -9.8% | 567,918 | -1.0% | 0.01% | -23.5% |
| Q3 2022 | $7,227,000 | +16.4% | 573,577 | -2.3% | 0.02% | +21.4% |
| Q2 2022 | $6,209,000 | -33.5% | 586,807 | +2.2% | 0.01% | -22.2% |
| Q1 2022 | $9,338,000 | +20.3% | 574,249 | +2.5% | 0.02% | +20.0% |
| Q4 2021 | $7,764,000 | +6.1% | 560,499 | +10.0% | 0.02% | 0.0% |
| Q3 2021 | $7,320,000 | +11.3% | 509,469 | +22.5% | 0.02% | +7.1% |
| Q2 2021 | $6,575,000 | +66.3% | 415,845 | +7.0% | 0.01% | +40.0% |
| Q1 2021 | $3,953,000 | +68.5% | 388,697 | +23.5% | 0.01% | +66.7% |
| Q4 2020 | $2,346,000 | +315.2% | 314,834 | +91.3% | 0.01% | +200.0% |
| Q3 2020 | $565,000 | +20.0% | 164,593 | +66.5% | 0.00% | 0.0% |
| Q2 2020 | $471,000 | +823.5% | 98,847 | +284.3% | 0.00% | – |
| Q1 2020 | $51,000 | – | 25,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |